Clinical Trial Update: Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing etoposide plus cisplatin vs temozolomide in MGMT-unmethylated glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Zhongnan Hospital | Conditions: MGMT-Unmethylated Glioblastoma | Phase 2 | Status: UNKNOWN